| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondrial Proteins | 10 | 2021 | 369 | 1.590 |
Why?
|
| DNA, Mitochondrial | 11 | 2022 | 311 | 1.590 |
Why?
|
| Mitochondrial Encephalomyopathies | 4 | 2020 | 26 | 1.510 |
Why?
|
| Mitochondrial Diseases | 8 | 2022 | 137 | 1.280 |
Why?
|
| Mutation | 20 | 2024 | 15179 | 1.060 |
Why?
|
| Mitochondria | 9 | 2021 | 1282 | 0.980 |
Why?
|
| Exome | 10 | 2018 | 1239 | 0.920 |
Why?
|
| 4-Aminobutyrate Transaminase | 3 | 2017 | 8 | 0.880 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 50 | 0.810 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2024 | 238 | 0.810 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 2017 | 105 | 0.800 |
Why?
|
| Haplotypes | 5 | 2014 | 856 | 0.750 |
Why?
|
| ATP-Dependent Proteases | 1 | 2020 | 9 | 0.740 |
Why?
|
| Brain Diseases | 3 | 2020 | 403 | 0.740 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2019 | 2 | 0.720 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 5539 | 0.690 |
Why?
|
| Pedigree | 15 | 2021 | 1890 | 0.680 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 264 | 0.650 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2018 | 22 | 0.640 |
Why?
|
| Alleles | 14 | 2021 | 2437 | 0.630 |
Why?
|
| Proteolysis | 1 | 2020 | 370 | 0.620 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 132 | 0.600 |
Why?
|
| Mutation, Missense | 6 | 2019 | 1152 | 0.600 |
Why?
|
| Phenotype | 11 | 2021 | 6295 | 0.600 |
Why?
|
| Brain Stem | 1 | 2018 | 175 | 0.590 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 413 | 0.580 |
Why?
|
| F-Box Proteins | 2 | 2015 | 96 | 0.570 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2015 | 3 | 0.550 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2015 | 17 | 0.550 |
Why?
|
| Craniosynostoses | 2 | 2017 | 98 | 0.530 |
Why?
|
| Lymphoma | 1 | 2024 | 1467 | 0.520 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 1439 | 0.510 |
Why?
|
| Infant | 23 | 2021 | 13310 | 0.510 |
Why?
|
| Oxidative Phosphorylation | 5 | 2021 | 253 | 0.490 |
Why?
|
| Genetics, Population | 2 | 2019 | 242 | 0.480 |
Why?
|
| Microcephaly | 2 | 2019 | 325 | 0.470 |
Why?
|
| Leigh Disease | 3 | 2019 | 39 | 0.470 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2021 | 4549 | 0.450 |
Why?
|
| Genetic Association Studies | 5 | 2021 | 1084 | 0.440 |
Why?
|
| RNA Helicases | 1 | 2013 | 101 | 0.440 |
Why?
|
| Linkage Disequilibrium | 3 | 2006 | 460 | 0.440 |
Why?
|
| Ectodermal Dysplasia | 1 | 2012 | 39 | 0.430 |
Why?
|
| Consanguinity | 1 | 2012 | 114 | 0.410 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 854 | 0.400 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 341 | 0.400 |
Why?
|
| Fibroblasts | 11 | 2021 | 1682 | 0.390 |
Why?
|
| Gene Frequency | 5 | 2019 | 1163 | 0.390 |
Why?
|
| Child, Preschool | 19 | 2021 | 16273 | 0.370 |
Why?
|
| Triglycerides | 1 | 2013 | 603 | 0.370 |
Why?
|
| Hyperglycemia | 1 | 2013 | 333 | 0.370 |
Why?
|
| Dyslipidemias | 1 | 2013 | 235 | 0.370 |
Why?
|
| Gene Pool | 1 | 2009 | 7 | 0.360 |
Why?
|
| Geography | 1 | 2009 | 140 | 0.350 |
Why?
|
| Precision Medicine | 1 | 2016 | 1154 | 0.340 |
Why?
|
| Electron Transport | 3 | 2020 | 79 | 0.330 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2195 | 0.320 |
Why?
|
| Proteins | 2 | 2015 | 1963 | 0.310 |
Why?
|
| Homozygote | 4 | 2016 | 717 | 0.310 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 2483 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 2 | 2020 | 264 | 0.280 |
Why?
|
| Genome, Human | 4 | 2010 | 1869 | 0.280 |
Why?
|
| Micronesia | 3 | 2013 | 6 | 0.280 |
Why?
|
| Base Sequence | 6 | 2018 | 4917 | 0.270 |
Why?
|
| Computational Biology | 3 | 2019 | 1271 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 1491 | 0.260 |
Why?
|
| Child | 20 | 2021 | 29154 | 0.260 |
Why?
|
| Infant, Newborn | 11 | 2021 | 8223 | 0.260 |
Why?
|
| Male | 33 | 2021 | 123000 | 0.250 |
Why?
|
| Genetics, Medical | 1 | 2006 | 143 | 0.250 |
Why?
|
| Humans | 46 | 2024 | 261506 | 0.250 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 2283 | 0.250 |
Why?
|
| Databases, Genetic | 2 | 2019 | 745 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 1054 | 0.240 |
Why?
|
| Genes, Recessive | 2 | 2015 | 200 | 0.240 |
Why?
|
| Europe | 3 | 2015 | 649 | 0.240 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 521 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2024 | 1678 | 0.230 |
Why?
|
| Female | 31 | 2021 | 141928 | 0.230 |
Why?
|
| Learning | 2 | 2019 | 403 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2024 | 86 | 0.230 |
Why?
|
| Ribonucleotide Reductases | 1 | 2022 | 51 | 0.210 |
Why?
|
| Gene Dosage | 2 | 2016 | 829 | 0.210 |
Why?
|
| Ubiquinone | 1 | 2021 | 37 | 0.200 |
Why?
|
| Electron Transport Complex IV | 2 | 2018 | 57 | 0.200 |
Why?
|
| Genes, Neoplasm | 1 | 2002 | 324 | 0.200 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 97 | 0.190 |
Why?
|
| Cerebellar Ataxia | 2 | 2018 | 72 | 0.190 |
Why?
|
| Fetal Growth Retardation | 2 | 2019 | 194 | 0.190 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 644 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2020 | 30 | 0.190 |
Why?
|
| Obesity | 1 | 2013 | 2884 | 0.190 |
Why?
|
| Codon | 1 | 2000 | 241 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2016 | 2086 | 0.180 |
Why?
|
| NADH Dehydrogenase | 1 | 2019 | 15 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2017 | 998 | 0.180 |
Why?
|
| Nucleosides | 2 | 2022 | 60 | 0.180 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 4233 | 0.180 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 62 | 0.180 |
Why?
|
| Dyskeratosis Congenita | 1 | 2019 | 26 | 0.180 |
Why?
|
| Young Adult | 5 | 2024 | 21445 | 0.180 |
Why?
|
| Heme | 1 | 2020 | 78 | 0.180 |
Why?
|
| Exoribonucleases | 1 | 2019 | 42 | 0.180 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 38 | 0.180 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2019 | 4 | 0.170 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 24 | 0.170 |
Why?
|
| Peptide Elongation Factors | 1 | 2019 | 17 | 0.170 |
Why?
|
| RNA, Transfer | 1 | 2019 | 77 | 0.170 |
Why?
|
| Genes, Dominant | 2 | 2016 | 331 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 129 | 0.170 |
Why?
|
| Glycoside Hydrolases | 1 | 2018 | 37 | 0.170 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 218 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 154 | 0.160 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2018 | 8 | 0.160 |
Why?
|
| Valine-tRNA Ligase | 1 | 2018 | 2 | 0.160 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 77 | 0.160 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 22 | 0.160 |
Why?
|
| Hypertrichosis | 1 | 2017 | 7 | 0.160 |
Why?
|
| Muscle, Skeletal | 5 | 2018 | 1270 | 0.160 |
Why?
|
| Neoplasms | 1 | 2024 | 15193 | 0.150 |
Why?
|
| Antiporters | 1 | 2017 | 71 | 0.150 |
Why?
|
| Incidence | 2 | 2019 | 5673 | 0.150 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 6089 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2019 | 192 | 0.150 |
Why?
|
| Adenine Nucleotide Translocator 1 | 1 | 2016 | 1 | 0.150 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 2 | 1 | 2016 | 4 | 0.150 |
Why?
|
| Malate Dehydrogenase | 1 | 2016 | 21 | 0.150 |
Why?
|
| Acidosis, Lactic | 2 | 2015 | 33 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 1516 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 148 | 0.150 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 88 | 0.140 |
Why?
|
| Language Development Disorders | 2 | 2019 | 167 | 0.140 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 86 | 0.140 |
Why?
|
| Genotype | 3 | 2021 | 4109 | 0.140 |
Why?
|
| Biopsy | 2 | 2021 | 3443 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 500 | 0.140 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2015 | 6 | 0.140 |
Why?
|
| Cholestanol | 1 | 2015 | 4 | 0.140 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2015 | 21 | 0.140 |
Why?
|
| Memory | 1 | 2019 | 429 | 0.140 |
Why?
|
| Americas | 1 | 2015 | 52 | 0.140 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 239 | 0.140 |
Why?
|
| Xanthomatosis | 1 | 2015 | 21 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 627 | 0.140 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 137 | 0.130 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3230 | 0.130 |
Why?
|
| Cholestasis | 1 | 2018 | 203 | 0.130 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 52 | 0.130 |
Why?
|
| Africa | 1 | 2015 | 142 | 0.130 |
Why?
|
| Asia | 1 | 2015 | 142 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2016 | 108 | 0.130 |
Why?
|
| Thiolester Hydrolases | 1 | 2015 | 34 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2018 | 546 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 545 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2016 | 116 | 0.130 |
Why?
|
| Siblings | 2 | 2015 | 285 | 0.130 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2014 | 14 | 0.130 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 889 | 0.120 |
Why?
|
| Phylogeny | 3 | 2018 | 826 | 0.120 |
Why?
|
| Adult | 6 | 2024 | 77950 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2014 | 92 | 0.120 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2013 | 8 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 63 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 70 | 0.120 |
Why?
|
| Adolescent | 8 | 2021 | 31252 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 989 | 0.120 |
Why?
|
| Multifunctional Enzymes | 1 | 2013 | 12 | 0.120 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 14 | 0.120 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2013 | 21 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 674 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2015 | 165 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2009 | 974 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 984 | 0.120 |
Why?
|
| Aging, Premature | 1 | 2013 | 38 | 0.120 |
Why?
|
| Cataract | 1 | 2015 | 218 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 42 | 0.110 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 82 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 269 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 69 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 610 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 63 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 3154 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 243 | 0.110 |
Why?
|
| Cholesterol | 1 | 2015 | 658 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 473 | 0.100 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1032 | 0.100 |
Why?
|
| Diarrhea | 1 | 2015 | 686 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 490 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 734 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2013 | 481 | 0.100 |
Why?
|
| Neuroimaging | 3 | 2021 | 403 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2013 | 434 | 0.100 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 233 | 0.100 |
Why?
|
| Population Groups | 1 | 2010 | 42 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2016 | 992 | 0.090 |
Why?
|
| Survival Rate | 1 | 2024 | 12221 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 492 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 875 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1819 | 0.090 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 424 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1697 | 0.090 |
Why?
|
| Biomarkers | 2 | 2019 | 5047 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 53 | 0.090 |
Why?
|
| Age of Onset | 3 | 2016 | 827 | 0.090 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 139 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2002 | 613 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2012 | 619 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 2045 | 0.080 |
Why?
|
| Microbiota | 1 | 2014 | 547 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1945 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 2139 | 0.080 |
Why?
|
| Staphylococcus Phages | 1 | 2006 | 1 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 3343 | 0.070 |
Why?
|
| Staphylococcus epidermidis | 1 | 2006 | 61 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 1265 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 2291 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2006 | 155 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2019 | 2947 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 7702 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2019 | 9244 | 0.060 |
Why?
|
| Prevalence | 1 | 2013 | 3260 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2019 | 1764 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2017 | 571 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 14551 | 0.060 |
Why?
|
| Metabolomics | 2 | 2018 | 478 | 0.060 |
Why?
|
| Drosophila | 2 | 2019 | 839 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2018 | 5270 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1503 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 5114 | 0.050 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2022 | 29 | 0.050 |
Why?
|
| Middle Aged | 2 | 2024 | 86204 | 0.050 |
Why?
|
| Brain | 4 | 2018 | 4113 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 394 | 0.050 |
Why?
|
| Software | 1 | 2009 | 1321 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 164 | 0.050 |
Why?
|
| Exons | 2 | 2016 | 1328 | 0.050 |
Why?
|
| Hominidae | 1 | 2000 | 37 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 1 | 2000 | 62 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2021 | 274 | 0.040 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2019 | 1 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 314 | 0.040 |
Why?
|
| Penetrance | 1 | 2019 | 126 | 0.040 |
Why?
|
| ADP-Ribosylation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Telomere Shortening | 1 | 2019 | 56 | 0.040 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2018 | 17 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 1471 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2018 | 25 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 430 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2021 | 6150 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2018 | 51 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2019 | 549 | 0.040 |
Why?
|
| DNA Replication | 1 | 2022 | 744 | 0.040 |
Why?
|
| Cutis Laxa | 1 | 2017 | 9 | 0.040 |
Why?
|
| Progeria | 1 | 2017 | 18 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 280 | 0.040 |
Why?
|
| Flumazenil | 1 | 2017 | 8 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 94 | 0.040 |
Why?
|
| Valine | 1 | 2018 | 176 | 0.040 |
Why?
|
| GABA Modulators | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 5637 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 133 | 0.040 |
Why?
|
| Malates | 1 | 2016 | 7 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 931 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 133 | 0.040 |
Why?
|
| Fumarates | 1 | 2016 | 30 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2016 | 125 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 217 | 0.040 |
Why?
|
| Animals | 6 | 2019 | 59536 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 342 | 0.040 |
Why?
|
| Serine Proteases | 1 | 2016 | 20 | 0.040 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2016 | 41 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2016 | 113 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2018 | 829 | 0.040 |
Why?
|
| Arabs | 1 | 2016 | 38 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 4821 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 2049 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 336 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2019 | 1258 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2017 | 218 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 197 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 368 | 0.030 |
Why?
|
| Time Factors | 1 | 2009 | 12926 | 0.030 |
Why?
|
| Facial Asymmetry | 1 | 2015 | 22 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 147 | 0.030 |
Why?
|
| Metabolome | 1 | 2018 | 344 | 0.030 |
Why?
|
| Carnitine | 1 | 2015 | 94 | 0.030 |
Why?
|
| Canada | 1 | 2015 | 429 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2015 | 611 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 475 | 0.030 |
Why?
|
| Prognosis | 3 | 2019 | 21713 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 803 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 204 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 2015 | 180 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2016 | 614 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 77 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 671 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 2074 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 886 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 733 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1351 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 172 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 1823 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 702 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 3438 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 1732 | 0.030 |
Why?
|
| Mice | 3 | 2019 | 34495 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 15694 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 1129 | 0.020 |
Why?
|
| Family | 1 | 2015 | 736 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 3570 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2000 | 6100 | 0.020 |
Why?
|
| Peptides | 1 | 1997 | 1479 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 1442 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2010 | 64 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 5710 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2019 | 37905 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 3203 | 0.020 |
Why?
|
| Algorithms | 1 | 2000 | 3890 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 4307 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4744 | 0.020 |
Why?
|
| Aged | 1 | 2013 | 70117 | 0.020 |
Why?
|
| Lysogeny | 1 | 2006 | 10 | 0.020 |
Why?
|
| Virus Assembly | 1 | 2006 | 51 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 4143 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 4804 | 0.020 |
Why?
|
| Introns | 1 | 2006 | 432 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2006 | 337 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 6942 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 4053 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 14889 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 106 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 957 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 997 | 0.010 |
Why?
|